Histiocytosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials
• Forums

Safety and Efficacy of DAY101 in Patients With Relapsed/Refractory LCH
Condition:   Langerhans Cell Histiocytosis Intervention:   Drug: DAY101 Sponsor:   Children's Oncology Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2022 Category: Research Source Type: clinical trials

Central China Rosai-Dorfman Disease Registry
Conditions:   Rosai-Dorfman Disease;   Langerhans Cell Histiocytosis Intervention:   Drug: Mycophenolate mofetil combined with oral prednisone Sponsor:   Tongji Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2022 Category: Research Source Type: clinical trials